These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 1071448)

  • 1. Myelofibrosis in chronic myeloid leukemia (report of a case).
    Attal HC; Grover S; Dua HS
    J Assoc Physicians India; 1976 May; 24(5):327-31. PubMed ID: 1071448
    [No Abstract]   [Full Text] [Related]  

  • 2. [Idiopathic myelofibrosis and secondary myelofibrosis in chromic myeloleukosis].
    Dul'tsin MS; Klimova NF; Cherntsova TA; Zakharova AV
    Probl Gematol Pereliv Krovi; 1967 Jan; 12(1):12-24. PubMed ID: 5245631
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-blastic meningeal leukemia during the myelofibrotic phase of chronic myeloid leukemia.
    Aversa P; Rambotti P; Falini B; Grignani F; Martelli MF
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(1):72-5. PubMed ID: 6164616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blastic crisis and myelofibrosis, simultaneous complications in a case of chronic myelocytic leukemia.
    Hassan K
    J Pak Med Assoc; 1981 Jul; 31(7):151-3. PubMed ID: 6792398
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronic myelofibrosis with myeloid metaplasia. The spectrum of clinical syndromes.
    Barosi G; Polino G
    Haematologica; 1987; 72(6):553-62. PubMed ID: 3126116
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnosis of chronic myelocytic leukemia].
    Krug K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):261-7. PubMed ID: 6168537
    [No Abstract]   [Full Text] [Related]  

  • 7. [Adenopathies in chronic myeloid leukemia (CML). Study of 161 cases].
    Paolino W; Infelise V; Degani G; Falda M; Paolino F; Fiorio C; Marmont F; Coda R
    Minerva Med; 1980 Aug; 71(30):2115-23. PubMed ID: 6933320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelofibrosis, osteolytic bone lesions and hypercalcemia in chronic myeloid leukemia.
    Licht A; Many N; Rachmilewitz EA
    Acta Haematol; 1973; 49(3):182-9. PubMed ID: 4198453
    [No Abstract]   [Full Text] [Related]  

  • 9. [Essential thrombocythemia in transformation to acute leukemia (FAB-M0) as a natural history from myelofibrosis with t(1;7)].
    Hayashi S; Iwama H; Uchida Y; Kawakubo K; Inatomi Y; Nagasu M; Miyazawa K; Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1997 May; 38(5):445-7. PubMed ID: 9194391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Femoral bone marrow in myelosclerosis].
    Waitz R; Mayer S; Mayer G; Oberling F
    Nouv Rev Fr Hematol; 1973; 13(3):416-21. PubMed ID: 4270598
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative clinical and histological investigations in chronic myeloid leukaemias ].
    Seewann HL; Jüttner F; Vykoupil KF
    Wien Klin Wochenschr; 1982 May; 94(10):270-2. PubMed ID: 6957071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medullary fibrosis and splenic erythroblastosis in chronic myeloid leukemia].
    Tanzer J; Najean Y; Jcquillat C; Ripault J; Chome J
    Nouv Rev Fr Hematol; 1967; 7(5):801-8. PubMed ID: 4230115
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pathological analysis in 37 cases on secondary myelofibrosis].
    Pan WS
    Zhonghua Bing Li Xue Za Zhi; 1988 Sep; 17(3):213-5. PubMed ID: 3228914
    [No Abstract]   [Full Text] [Related]  

  • 14. Myelofibrosis and megakaryoblastic transformation of chronic myelogenous leukemia associated with intrinsic platelet dysfunction: hematological, histological and ultrastructural findings.
    Cortelazzo S; D'Emilio A; Battista R; Ricciardi O; Dini E; Visonà A; Montaguti A; Pennelli N
    Haematologica; 1984; 69(6):671-81. PubMed ID: 6441743
    [No Abstract]   [Full Text] [Related]  

  • 15. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics of the course of myelocytic leukemia associated with myelofibrosis].
    Klimova NF; Zakharova AV; Korenevskaia MI; Aksenova OV
    Probl Gematol Pereliv Krovi; 1975 Feb; 20(2):26-9. PubMed ID: 1059075
    [No Abstract]   [Full Text] [Related]  

  • 17. The reversal of myelofibrosis associated with chronic myelogenous leukemia after allogeneic bone marrow transplantation.
    Oblon DJ; Elfenbein GJ; Braylan RC; Jones J; Weiner RS
    Exp Hematol; 1983 Aug; 11(7):681-5. PubMed ID: 6350032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of chronic myeloid leukemia].
    Mey U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(2):268-74. PubMed ID: 6168538
    [No Abstract]   [Full Text] [Related]  

  • 19. Myelofibrosis in myeloid malignancies with 3q26 cytogenetic abnormalities.
    Sancho JM; Ribera JM; Granada I; Navarro JT; Millá F; Feliu E
    Haematologica; 2000 May; 85(5):554-5. PubMed ID: 10800180
    [No Abstract]   [Full Text] [Related]  

  • 20. [Combined splenic scintigraphy and function test: a new differential diagnostic criterion in chronic myeloid leukemia and myelofibrosis].
    Roux A; Fischer J; León A; Wolf R
    Verh Dtsch Ges Inn Med; 1969; 75():510-3. PubMed ID: 5275880
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.